AKT1 and type 2 diabetes mellitus: Complementary molecular docking studies demonstrated robust binding affinities between caffeic acid and key proteins implicated in T2DM pathophysiology, namely PIK3CA, α-glucosidase, and AKT1, supporting its potential for therapeutic modulation at the intracellular signaling level.